Home > Boards > US OTC > Biotechs >

Know Labs, Inc. (KNWN)

Add KNWN Price Alert      Hide Sticky   Hide Intro
Moderator: lofdog3
Search This Board: 
Last Post: 9/17/2020 12:12:10 AM - Followers: 61 - Board type: Free - Posts Today: 0

About Know Labs, Inc.
Know Labs, Inc. (f/k/a Know Labs Incorporated) is a public company whose shares trade under the stock symbol “KNWN.” The company’s technology directs structured light or radio waves through a substance or material to capture a unique molecular signature. The Company refers to these signatures as ChromaID™ and Bio-RFID™. ChromaID and Bio-RFID are used to identify, detect, or diagnose substance markers or biomarkers that may be invisible to the human eye. ChromaID and Bio-RFID scanner modules can be integrated into a variety of mobile or bench-top form factors. This patented and patent pending, award-winning technology makes it possible to effectively conduct analyses that could only previously be performed by invasive and/or large and expensive lab-based tests. For more information on Know Labs, visit the company’s website at http://bit.ly/knowlabs

Historically, the Company focused on the development of our proprietary ChromaID technology. Using light from low-cost LEDs (light emitting diodes) we map the color of substances, fluids and materials and with our proprietary processes we can authenticate, identify and diagnose based upon the color that is present. The color is both visible to us as humans but also outside of the humanly visible color spectrum in the near infra-red and near ultra-violet and beyond. Our ChromaID scanner sees what we like to call “Nature’s Color Fingerprint.”  Everything in nature has a unique color identifier and with ChromaID we can see it, and identify, authenticate and diagnose based upon the color that is present.  Our ChromaID scanner is capable of uniquely identifying and authenticating almost any substance or liquid using light to create, record and detect its unique color signature. We will continue to develop and enhance our ChromaID technology and extend its capacity. More recently, we have focused upon extensions and new inventions that are derived from and extend beyond our ChromaID technology.   We call this technology Bio-RFID.  The rapid advances made with our Bio-RFID technology in our laboratory have caused us to move quickly in to the commercialization phase of our Company as we work to create revenue generating products for the marketplace.  
ChromaID and Bio-RFID:  Foundational Platform Technologies
Our ChromaID and Bio-RFID technologies provide a platform upon which a myriad of applications can be developed.  As platform technologies, they are analogous to a smartphone, upon which an enormous number of previously unforeseen applications have been developed.  ChromaID and Bio-RFID technologies are “enabling” technologies that bring the science of electromagnetic energy to low-cost, real-world commercialization opportunities across multiple industries. The technologies are foundational and, as such, the basis upon which the Company believes a significant business can be built.
As with other foundational technologies, a single application may reach across multiple industries. The ChromaID technology can, for example effectively differentiate and identify different brands of clear vodkas that appear identical to the human eye. By extension, this same technology can identify pure water from water with contaminants present. It can provide real time detection of liquid medicines such as morphine that have been adulterated or compromised. It can detect if jet fuel has water contamination present. It could determine when it is time to change oil in a deep fat fryer. These are but a few of the potential applications of the ChromaID technology based upon extensions of its ability to identify different clear liquids.
Similarly, the Bio-RFID technology can non-invasively identity the presence and quantity of glucose in the human body.  By extension, there may be other molecular structures which this same technology can identity in the human body which, over time, the Company will focus upon. They may include the monitoring of drug usage or the presence of illicit drugs.  They may also involve identifying hormones and various markers of disease. 
The cornerstone of a company with a foundational platform technology is its intellectual property.  We have pursued an active intellectual property strategy and have been granted 12 patents.  We currently have 20 patents pending.  We possess all right, title and interest to the issued patents.

About Our Team

Phil Bosua
Chief Executive Officer

Phil Bosua is an internationally recognized inventor and innovator. His expertise in lighting lead him to found LIFX (www.lifx.com) where he created the world’s first commercial smart light bulb. The 2012 crowdsourcing launch of his smart light bulb raised $1.3 million in six days and attracted $12 million in funding from Sequoia Capital (www.sequoiacap.com). This groundbreaking invention earned him the prestigious Edison Gold Award (www.edisonawards.com) presented by Elon Musk to innovators who create products that have a positive impact on the world. Bosua also founded RAAI, Inc., where he continued his innovative creation of new uses of light. Bosua said, “The time I have spent in the Visualant lab working on advancing their technology has been some of the most scintillating moments of my career. Ron Erickson and Visualant have provided support to allow me and the lab team to explore new products and discover new technologies. I’m excited by the technology platform we are creating, knowing that it will benefit millions of people around the world and be equally as good for our shareholders.”

LinkedIn: http://bit.ly/2yeBNR9
Press Release: http://bit.ly/2HJRZsJ

Ronald P. Erickson
CFO, President and Chairman of the Board.

Mr. Erickson has been a director and officer of the Company since April 24, 2003. He currently serves as the Company's Chairman, Chief Executive Officer and President. He was appointed to the positions of CEO and President on November 10, 2009. Earlier, he was appointed President and Chief Executive Officer of the Company on September 29, 2003, and resigned from this position on August 31, 2004 at which time he was appointed Chairman of the Board. A seasoned executive with more than 30 years of experience in the high technology, telecommunications, micro-computer, and digital media industries, Mr. Erickson was the founder of Know Labs. In addition to his Know Labs responsibilities he also serves as Chairman of ivi, Inc. a streaming media company and eCharge Corporation an Internet based transaction processing company. He is formerly Chairman, CEO and Co-Founder of Blue Frog Media, a mobile media and entertainment company; Chairman, CEO and Co-founder of GlobalTel Resources, a provider of telecommunications services; Chairman, Interim President and CEO of Egghead Software, Inc. the large software reseller where he was an original investor; Chairman and CEO of NBI, Inc.; and Co-founder of MicroRim, Inc. the database software developer. Earlier, Mr. Erickson practiced law in Seattle and worked in public policy in Washington, DC and New York, NY. Additionally, Mr. Erickson has been an angel investor and board member of a number of public and private technology companies. Mr. Erickson has a BA from Central Washington University, a MA from the University of Wyoming and a JD from the University of California, Davis. He is licensed to practice law in the State of Washington and the District of Columbia.

LinkedIn: http://bit.ly/2t2oE7T

Bill Owens
Know Labs Board of Directors

Admiral Owens is currently the co-founder and executive chairman of Red Bison Advisory Group, a company which identifies opportunities with proven enterprises in China, the Middle East, and the United States and creates dynamic partnerships focusing on: natural resources (oil, gas and fertilizer plants), real estate, and information and communication technology. Most recently, he was the chairman of the board of CenturyLink Telecom, the third largest telecommunications company in the United States and was on the advisory board of SAP USA. Owens serves on the board of directors at Wipro Technologies and is a director of the following private companies: Humm Kombucha, a beverage company and Versium. Owens is on the advisory board of the following private companies: Healthmine, Platform Science, Sarcos, Sierra Nevada Corporation, and Vodi. Owens is on the board of trustees at EastWest Institute, Seattle University, and an advisor to the Fiscal Responsibility Amendment (CFFRA) Association which aims to establish a balanced budget amendment to the US Constitution. He is also a member of the Council of Foreign Relations.

LinkedIn: http://bit.ly/2K6DJwx
Press Release: http://bit.ly/2JzG7PO


Know Labs, Inc.

Jordyn Theisen, Ph. 206-903-1351
Email: jordyn@knowlabs.co

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/KNWN/company-info
Ticker: $KNWN
OTC Market Tier: OTCQB
CIK code: 0001074828
Company name: Know Labs, Inc.
Company website: http://bit.ly/knowlabs
Incorporated In: NV, USA

##### recent news/filings

Latest filings: http://www.otcmarkets.com/stock/KNWN/filings
Latest financials: http://www.otcmarkets.com/stock/KNWN/financials
Latest news: http://www.otcmarkets.com/stock/KNWN/news - http://finance.yahoo.com/q/h?s=KNWN+Headlines
Corporation WIKI:
Corporate website internet archive: http://bit.ly/knowlabs


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KNWN News: Small Company Offering and Sale of Securities Without Registration (d) 08/06/2020 06:05:36 AM
KNWN News: Securities Registration Statement (s-1/a) 07/08/2020 04:59:24 PM
KNWN News: Securities Registration Statement (s-1) 06/30/2020 04:18:44 PM
KNWN News: Current Report Filing (8-k) 06/02/2020 01:37:34 PM
KNWN News: Amended Current Report Filing (8-k/a) 05/28/2020 05:28:03 PM
#2404   I guess the good side of that is tjguy 09/17/20 12:12:09 AM
#2403   Post of the week. Agree 100% lofdog3 09/16/20 04:53:07 PM
#2402   I think we are dealing with a CEO Tsponberg 09/16/20 02:05:48 PM
#2401   Ahhh yes, so calling for a buy out BevBoson 09/16/20 01:27:48 PM
#2400   They have released data in the past and BevBoson 09/16/20 01:26:40 PM
#2399   I would think the release of the prototype RMacchio 09/16/20 12:14:27 PM
#2398   I think they are very reluctant to show Rickilbe 09/16/20 12:03:30 PM
#2397   I think the stock will languish until they RMacchio 09/16/20 10:38:27 AM
#2396   They can't start testing until they have the RMacchio 09/16/20 10:34:22 AM
#2395   I have to admit, I don't like the tjguy 09/16/20 09:58:53 AM
#2394   In an interview last year the CEO said EagleD 09/16/20 08:07:20 AM
#2393   Once we get proof of concept from the tjguy 09/16/20 12:04:41 AM
#2392   Where did you hear this buyout information? BevBoson 09/15/20 09:47:53 PM
#2391   If you look through the 10-K you see RMacchio 09/15/20 04:47:27 PM
#2390   Crazy someone dumped 24,000 shares at $2.50. They Tsponberg 09/15/20 02:43:35 PM
#2389   Picked up another 1K today on the dip! tjguy 09/15/20 09:52:43 AM
#2388   Ron Ericson presented at the LD Micro conference RMacchio 09/15/20 08:37:26 AM
#2387   I do see a dexcom commercial like every 737Flyer 09/15/20 07:58:49 AM
#2386   I am not up on that, but they tjguy 09/15/20 07:44:12 AM
#2385   How are they looking in terms of cash GeorgioD 09/15/20 07:27:51 AM
#2384   One idea I heard floated by them is tjguy 09/14/20 10:58:49 PM
#2383   I think they will license the hell out ScoutsOut 09/14/20 08:42:09 PM
#2382   A follow-up on the buyout rumor... I guess RMacchio 09/14/20 08:13:03 PM
#2381   I wouldn't mind a buyout if the price RMacchio 09/14/20 08:09:56 PM
#2380   My 2nd largest holding. I am hearing EagleD 09/14/20 06:28:59 PM
#2379   100% agree DollarSquad 09/10/20 10:42:00 AM
#2378   No news is not good news. IMO BevBoson 09/10/20 09:56:34 AM
#2377   Saying... "No news is good news" said to Rickilbe 09/10/20 07:05:24 AM
#2376   I would have to agree, if they have BevBoson 09/09/20 08:29:29 PM
#2375   I'm no scientist but I don't believe that ROCKTHE WORLD 09/09/20 05:56:29 PM
#2374   Agreed! No company is completely transparent in their Tsponberg 09/09/20 02:23:51 PM
#2373   Yes, that is what the video said. However, tjguy 09/09/20 09:26:47 AM
#2372   RMacchio is correct DollarSquad 09/05/20 09:07:45 AM
#2371   You apparently didn't view the BioPub video from RMacchio 09/05/20 06:53:26 AM
#2370   You are at least 6 to 7 months Regis999 09/04/20 08:20:23 PM
#2369   The "working model" is a circuit board with RMacchio 09/04/20 07:14:54 PM
#2368   I don't believe they do. They have a DollarSquad 09/04/20 05:09:19 PM
#2367   They have had the working model since the Regis999 09/04/20 03:35:53 PM
#2366   Thanks for whoever filled me at 2.61. Loaded more. 737Flyer 09/04/20 03:10:03 PM
#2365   Yes, we eagerly await the Frankenstine. Tsponberg 09/04/20 03:06:48 PM
#2364   As has been mentioned multiple times in this RMacchio 09/04/20 01:59:30 PM
#2363   The Mayo Clinic delay certainly was a curve Rickilbe 09/04/20 11:19:17 AM
#2362   So from the presentation we learned that: tjguy 09/01/20 09:23:57 PM
#2361   Ron said NYSE uplist or NASDAQ. I had Tsponberg 09/01/20 06:48:56 PM
#2360   Thanks for that. It gives us a glimpse Tsponberg 09/01/20 06:16:09 PM
#2359   And 5 times present Market Cap for 1% curious924 09/01/20 05:15:15 PM
#2358   I listened to Ron's presentation. Learned a few Rickilbe 09/01/20 04:33:58 PM
#2357   I sent a note to KNWN 3 weeks RMacchio 09/01/20 02:35:44 PM
#2356   OK, good for them, but it seems it tjguy 08/28/20 08:03:50 PM
#2355   The Mayo Clinic would need the final product RMacchio 08/28/20 02:40:03 PM
Consent Preferences